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Purpose. This systematic review critically analyzes the literature on the eﬀectiveness of treadmill training (TT), body-weight-
supported TT (BWSTT), and robot-assisted TT (RATT) in persons with multiple sclerosis (MS), with focus on gait-related
outcome measurements. Method. Electronic databases (Pubmed, Pedro, Web of Science, and Cochrane Library) and reference
lists of articles and narrative reviews were searched. Pre-, quasi- and true-experimental studies were included if adult persons with
MS were involved in TT, BWSTT, or RATT intervention studies published before 2012. Descriptive analysis was performed and
two researchers scored the methodological quality of the studies. Results. 5 true- and 3 preexperimental studies (mean quality
score: 66%) have been included. In total 161 persons with MS were involved (TT, BWSTT, or RATT, 6–42 sessions; 2–5x/week; 3–
21 weeks). Signiﬁcant improvements in walking speed and endurance were reported. Furthermore, improvements of step length,
double-supporttime,andExpandedDisabilityStatusScalewerefound.Conclusions.Thereisalimitednumberofpublishedpapers
related to TT in persons with MS, concluding that TT, BWSTT, and RATT improve the walking speed and endurance. However, it
is not clear what type of TT is most eﬀective. RCTs with larger but more homogeneous populations are needed.
1.Introduction
Multiple sclerosis (MS) is a disease causing a widespread
degeneration of the central nervous system which gradually
results in severe neurological deﬁcits [1]. This neurode-
generative autoimmune disease has a high risk (incidence
ranges from 0.1 to 0.2%) in the United States, Canada,
Russia, Israel, Europe, New Zealand, and parts of Australia
[2] .T h ep a t t e r n so fs y m p t o m sa r ec o m p l e x ,v a r i a b l e ,a n d
unpredictable [1], translating to extreme debilitation for
some,whereothersconducttheirdailyliveswithnodramatic
changes [2]. The variable distribution of demyelization and
axonal loss may lead to disorders of strength, sensation,
coordination and balance, as well as visual, cognitive, and
aﬀective deﬁcits, which may lead to severe progressive
limitations of functioning in daily life [3]. The motor
problems include muscle weakness, partial or full paralysis,
stiﬀness, slurred speech, twitching muscles, tremor, and
spasticity [2]. Locomotor disability in persons with MS can
be considered as an emergent characteristic deriving from
several mechanisms of functional impairments, including
coordinationofpostureandgait[4,5].Physicalimpairments
strongly inﬂuence the level of independence that a person
with MS is able to achieve [6]. Compton and Coles (2008)
described the diﬀerent signs and symptoms in function of
the diﬀerent aﬀected sites of the nervous system (cerebrum,
optic nerve, cerebellum and cerebellar pathways, brainstem,
spinalcord,andothersites)[7].Thesevarioussymptomscan
appear in each of the four clinically deﬁned phenotypes of
MS: relapsing-remitting (RR) MS (approximately 55% of the2 Multiple Sclerosis International
cases), secondary progressive (SP) MS (approximately 30%
of the cases), primary progressive (PP) MS (approximately
10% of the cases), progressive relapsing (PR) MS (approxi-
mately 5% of the cases). Each type has its own features and
progression [2, 8].
Because of the wide variety of symptoms the rehabilita-
tion process in persons with MS is complex and should be
multidisciplinary and personspeciﬁc. Approximately 75% of
the persons with MS experiences mobility problems [9, 10],
such as a reduced walking ability [4] .P e r s o n sw i t hM S
frequently show changes and a greater variability in lower
limb kinematics during gait such as reduced stride length
and prolonged double limb support time, and in walking
speed compared with healthy controls [11, 12]. There is
a correlation between strength reduction, especially of the
hamstrings, and gait impairment, whatever the clinical type
of MS [4].
One of the primary aims of rehabilitation for persons
withMSistoincreasetheirlevelsofactivityandparticipation
and so increase their independence [3]. Many factors (phys-
ical, cognitive, emotional, and patient’s starting proﬁle of
impairment and disability) may determine the rehabilitation
beneﬁt [6]. Gait rehabilitation is an important part of the
therapy to reach the previous goal. Because gait problems
can lead to an increased risk of falling, it is important to
include balance and walking training in the therapy program
[13]. Physiotherapy in chronic MS patients is associated with
improved mobility compared with no treatment [10, 14, 15],
but the beneﬁt may only last a few weeks [14, 15].
Beside over-ground gait training, diﬀerent types of gait
rehabilitation on a treadmill are possible, such as, treadmill
training (TT) with manual assistance and support, treadmill
training in combination with body weight support (BWS),
and treadmill training with BWS in combination with robot
assistance (RA). Since the late 1990s robot-assisted gait reha-
bilitation has become popular in neurological rehabilitation.
Diﬀerent systems are commercially available, including the
“Lokomat” [16, 17] and the “Gait trainer” [18]. Actually
TT, with or without BWS and/or RA, is a frequently used
techniqueforgaitrehabilitationinneurologicaldiseasessuch
as spinal cord injury (SCI), stroke, and in Parkinson’s disease
[19–26]. In these populations of patients the results are fairly
good, for example the patients walk more symmetrically
with higher velocities resulting in a facilitation of the paretic
muscles and have a more eﬃcient gait [19]. But, it is unclear
which type of gait rehabilitation therapy is the most eﬀective
[21, 22, 27].
At the moment, no systematic reviews were found about
gait-related outcome measurements in TT in persons with
MS.Thissystematicliteraturereviewfocusesontheeﬀective-
ness of TT with or without BWS and/or RA in persons with
MS, measured with gait-related outcome measurements.
The research questions of this paper are (1) do persons
with MS improve in gait-related outcome measurements
(walking speed and endurance, Expanded Disability Status
Scale (EDSS-score) and gait parameters) after TT, with or
without BWS and/or RA?; (2) is any of the therapies (TT,
BWSTT or RATT) superior to the other therapies in terms of
gait-related outcome measurements?; (3) what are the long
term-eﬀects?
2. Methods
A computerized search was conducted for English, French,
and Dutch articles published before 2012. The electronic
databases PubMed, Web of Sciences, Cochrane Library, and
Pedro were investigated. Keywords and MeSH-terms, and
their combinations were organized following the Population,
Intervention,Comparison,andOutcome(PICO)model[28]
and are reported in Table 1. Also the reference lists of the
articles and narrative reviews were scanned for relevant
publications.
Included were studies on adult (+19 years) persons with
MS. Subjects with MS diagnosis were included, whatever the
type, grade, or duration of their disease. Eﬀect studies on
TT, with or without BWS and/or RA with the primary aim
of improving gait function and which encompassed gait-
related outcome measurements, were included. Excluded
were studies where TT was used in combination with other
interventions than BWS and RA. Studies using functional
electrostimulation, studies with outcome exclusively focused
on physical capacity, electromyographic or kinematic data
and/or cardiorespiratory functioning were excluded. Also
excluded were animal studies and studies on children. Pre-,
quasi- and true-experimental studies were included, with
exception of studies only presented as an abstract of a
congress.
3. Results
The ﬂowchart (Figure 1) presents an overview of the search
strategy. Ultimately, eight studies were included in this
systematic review [29–36]. Five studies were true experimen-
tal trials (randomized controlled trials, RCTs [29–33]), no
studies were quasi-experimental trials (clinical trials without
random assignment) and three studies were preexperimental
trials (one study was a randomized trial without comparison
group and two studies were case reports with four and
six subjects [34–36]) [37]. The methodology checklist:
“Evaluation of quality of an intervention study” was used
to assess the quality of the included studies [38]. Two
researchers scored the studies independently and Cohen’s
kappa was used to test the interrater reliability. This check-
list scores the internal validity of the studies, and consists
of seven subscales: study question, study design, subjects,
intervention, outcomes, analysis and recommendations. The
Cohen’s Kappa between the scores of the two researchers was
0.77 (SD 0.13), indicating a good agreement between the
scores of the two researchers. The consensus method was
used in case of disagreement. In Table 2 an overview of the
scores of the Methodology checklist is presented. All studies
scored between 48 and 79% on the methodological checklist,
with the highest scores for the RCTs (between 62.5 to 79%)
and the lowest scores for the case reports (48 and 54%).
The mean score was 31.5/48 (SD 5.8) or 66%. We decided
to includ all the eight studies. The lower scores were mainlyMultiple Sclerosis International 3
Table 1: Key words and MeSH terms and their combinations that were used in the literature search. In the search keys: between the columns
“AND” was used. The key words “Multiple Sclerosis”, “Gait”, “Walking”, “Exercise”, and “Exercise Therapy” were used as MeSH terms in the
database PubMed.
P: population I: intervention C: comparison O: outcome
Multiple
sclerosis
( W a l k i n g )O R( g a i t )O R( s t e p )A N D
(robot-assisted) OR (body weight support) OR (body weight
supported) OR (partial body weight) OR (partial body weight
supported) OR (weight-support) OR (weight-supported) OR
(treadmill) OR (motorized rehabilitation) OR (motorized
training) OR (automatic orthoses) OR (locomotor
rehabilitation) OR (locomotor training) AND
(exercise) OR (exercise therapy) OR (training) OR
(rehabilitation)
Conventional
therapies
(walking speed) OR (gait speed)
OR (walking distance) OR
(walking capacity) OR (walking
endurance) OR (stride length)
OR (step length)
caused by poor quality of the study design, the intervention,
and the analysis of the results.
A total of 161 persons with MS participated in the
diﬀerent studies (patients characteristics, e.g., gender, EDSS
score, age, and type MS were reported in Table 3). Two
studies measured the same subjects, although they described
diﬀerent measurement outcomes and measured the outcome
on diﬀerent moments during and after training [33, 34].
Hence, 145 diﬀerent persons with MS participated in the
studies. In total 34 drop-outs were described. Beer et al.
(2008) described ﬁve drop-outs in the RATT group which
two were directly related to treatment (skin irritation by
the ﬁxation belt at the knee/lower leg with full recovery),
and there was one drop-out in the conventional walking
therapy (CWT) group not related to the treatment [29]. In
the study of Vaney et al. (2011) eighteen drop-outs were
described, eight in the RATT group (family reason, too weak,
did not want to continue, problem with catheterization)
and ten in the walking group (language problems, fracture
before rehabilitation, too tired, did not want to continue, MS
exacerbation) [30]. Of the nineteen subjects in the studies
of Newman et al. (2007) and van den Berg et al. (2006)
three dropped out for reasons unrelated to training or their
MS [33, 34]. Schwartz et al. (2011) described four drop-outs
after four weeks treatment, one in the CWT group (patients:
uncooperative with treatment) and three in the RATT group
(two patients: uncooperative with treatment, one patient
participated in another study). They reported four more
drop-outs after three months followup and six more drop-
outs after six months followup [31]. More females (63%
without drop-outs) compared to males participated in the
studies. One study did not reported the gender of their
participants [30]. If reported no subject had a relapse within
eight weeks [33, 34], three months [29–31], six months [32],
or one year [36].
Diﬀerent protocols of TT were reported among the
included studies (Design, type, walking speed, level of
BWS, and duration and frequency of the interventions were
reported in Table 3).
All included studies measured walking speed: two studies
using the timed 25-foot walk (T25FW) [32, 35], one study
the twenty-meter walk test (20MWT) [29], and four studies
the ten-meter walk test (10MWT) [31, 33, 34, 36]. One
study uses the 10MWT and the three-minutes walk test
(3MWT)tomeasurewalkingspeed[30].Walkingendurance
was measured in all the selected studies, except two [30, 35].
In three studies the walking endurance was measured with
the six-minute walk test (6MWT) [29, 31, 32, 36] and in
two studies with the two-minute walk test (2MWT) [33, 34].
The tests were recorded during over-ground walking with
exception of one study in which the 6MWT was done on a
treadmill [32]. Two RCTs [31, 32] and the two case reports
[35, 36] used the EDSS score to measure the disability. Beer
et al. (2008) measured the stride length and Newman et al.
(2007) measured the stride length, the cadence, gait cycle
time, and foot contact time by using the GAIT-Rite mat [39].
We calculated the eﬀect size (Cohen’s d) if the means and
standard deviations of the results in the diﬀerent included
studies were reported (Table 4).
3.1. Research Question 1: Do Persons with MS Improve in
Gait-Related Outcome Measurements (Walking Speed and
Endurance, EDSS-Score, and Gait Parameters) after TT, with
or without BWS and/or RA?
3.1.1. Walking Speed. In the eight studies that reported
walking speed an improvement was measured after training
in almost all subjects. Pilutti et al. (2011) reported that
during training the walking speed on the treadmill increased
signiﬁcantly (P<0.001) from 1.1 ± 0.10 kmph (0.31m/s)
to 1.6 ± 0.09kmph (0.44m/s), and a mean change of 18%
on the T25-FW was measured [35]. In the controlled trial
of Giesser et al. (2007) one subject who could not walk
the 10MWT before completed the test after training. All
subjects who could perform the task could walk faster over
ground after training as compared with before training [36].
Lo and Triche (2008) reported a decrease in average time
for the T25FW after training. Total change by the end of
twelve sessions showed a 31% improvement in the T25FW.
Eﬀect size calculations show that there was a small eﬀect in
the Lokomat-BWSTT group at the diﬀerent measurement
times and a large eﬀect in the BWSTT-lokomat group but
only when comparing the data on baseline with the data
after the BWSTT training sessions [32]. Beer et al. (2008)
reported that the eﬀect sizes of diﬀerences between RATT
and CWT showed a large eﬀect (>0.6) for walking velocity
on the 20MWT. A pre-post-within group analysis revealed4 Multiple Sclerosis International
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.Multiple Sclerosis International 5
966 papers after 
keyword search
907 were excluded after 
        reading title
Pubmed (236), Pedro 
(118), web of science 
(308), Cochrane library 
              (304)
Pubmed (218), Pedro 
(108), web of science 
(291), Cochrane library 
              (290)
59 extracted for more 
detailed application 
        (abstract)
32 after removing 
      duplicates
24 were excluded after
   reading full texts
Other
No references were added
8 studies ultimately
         included
Pubmed (20), Pedro 
(10), web of science 
(17), Cochrane library 
              (14)
outcome measurement 
 (1), no treadmill (15),
 combination therapies 
(2), no full text (4), other
    design (1) and other
       population (1)
Figure 1: Flowchart of the search strategy.
a signiﬁcant improvement of walking speed in both groups
(RATT: 0.21m/s (range 0.09–0.27) to 0.27m/s (range 0.15
to 0.49), P = 0.003 and CWT: 0.24m/s (range 0.17 to
0.28) to 0.31m/s (range 0.19 and 0.42), P = 0.026). They
reported that after a follow-up period of six months the
outcome values had returned to baseline in both groups
[29]. Van Den Berg et al. (2006) described that after seven
weeksindividualsofthetrainedgroupsigniﬁcantlyimproved
their 10MWT more, compared with the untrained group
(P<0.05). At week twelve, after a four-week rest period,
walking performance returned towards baseline scores [33].
Newman et al. (2007) reported that the mean 10MWT time
reduced from 15.6 seconds (SD: 5.6, range 7.8–28.1) to 13.9
seconds (SD: 5.3, range 7.5–27.0), P = 0.016 [34]a f t e rT T .
In the study of Schwartz et al. (2011) at the end of the
treatment only in the CWT group, and not in the RATT
group, a signiﬁcant improvement (small eﬀect size) on the
10MWT was found (mean change from baseline: 0.1m/s,
SD 0.2) [31]. Vaney et al. (2011) show improvements (small
eﬀect size) on the 10MWT and the 3MWT in the walking
group (10MWT: 0.09m/s, SD 0.17, 95% CI: 0.01 to 0.16,
3MWT: 0.11m/s, SD 0.17, 95% CI: 0.04 to 0.18) and in the
RATT group (10MWT: 0.03m/s, SD 0.09, 95% CI: −0.00 to
0.07,3MWT:0.03m/s,SD0.10,95%CI: −0.01to0.07)[30].
3.1.2. Walking Endurance. In all six studies that reported
walking endurance an improvement was measured after
training in almost all subjects. One case report showed that
threeoutoffoursubjectsshowedimprovementinendurance
as measured with the 6MWT and two subjects who could
not walk the 6MWT before completed the test after training
[36]. Of the thirteen subjects of Lo and Triche (2008) all
but one person had an improvement in distance covered
in the 6MWT after training. The total change by the end
of the twelve sessions showed a 38.5% improvement for
the 6MWT on the treadmill (large eﬀect in the Lokomat-
BWSTTgroupandamoderateeﬀectintheBWSTT-Lokomat
group)[32].ComparingRATTandCWTshowedamoderate
eﬀect for the 6MWT distance, favoring RATT (RATT: 74m
(range 34–97) to 81m (range 44–137), P = 0.006/CWT:
87m (range 62–101) to 83m (range 64–145), P = 0211)
[29]. The trained and untrained subjects in the study of
van den Berg et al. (2006) signiﬁcantly improved their
2MWT times after seven weeks and after week twelve the
walking performance returned towards baselines scores. A
small eﬀect was calculated in the delayed training group
[33]. The walking endurance of the subjects in the study of
Newman et al. (2007) increased from a mean 88.2m (SD:
32.2, range 44.6–154.0m) to 94.3m (SD: 32.2, range: 55.2 to
156.1m), P = 0.020 on the 2MWT distance [34]. Schwartz
et al. (2011) reported at the end of the treatment a signiﬁcant
improvement (small eﬀect size) on the 10MWT in the CWT
group (mean change from baseline 30.2m, SD: 37.6) but not
in the RATT group.
3.1.3. EDSS Score. Four studies measured an improvement
in EDSS score after training: Lo and Triche (2008) in eleven
of the thirteen subjects (baseline scores between 7 and 3.5
and after training a gain from 0.5 to 2 points, P = 0.001,
large eﬀect size) and Pilutti et al. (2011) and Giesser et al.
(2007) both in only one subject (both a decrease of 0.5 after
training). In this last case study it was reported that the
subject who did improve in EDSS score (baseline: 7.0-after
training: 6.5) started from a higher functional level and was
less neurologically impaired in terms of muscle strength and
balance than the other three subjects [36]. Schwartz et al.
(2011) described that at the end of the treatment both RATT
andCWTgroupsshowedasigniﬁcantimprovementinEDSS
score (moderate eﬀect). In the RATT the mean change from
baseline was −0.29 (SD 0.4, pre: 6.2 SD 0.5; post: 5.9 SD 0.6)
and in the CWT −0.31 (SD 0.3, pre: 6.0 SD 0.6; post: 5.7 SD
0.7) [31].
3.1.4. Gait Parameters. Ad e c r e a s ei nd o u b l es u p p o r tt i m e
in twelve of the thirteen subjects (P = 0.0 3 ) ,a n dat r e n d6 Multiple Sclerosis International
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m
e
n
t
s
A
s
s
e
s
s
m
e
n
t
t
i
m
e
s
G
a
i
t
-
r
e
l
a
t
e
d
o
u
t
c
o
m
e
m
e
a
s
u
r
e
m
e
n
t
s
B
e
e
r
e
t
a
l
.
(
2
0
0
8
)
[
2
9
]
t
r
u
e
e
x
p
.
(
7
9
%
)
2
9
(
3
5
:
6
d
r
o
p
-
o
u
t
s
;
5
i
n
R
A
T
T
a
n
d
1
i
n
C
W
T
)
1
2
m
/
2
3
f
R
A
T
T
:
7
m
/
1
2
f
,
C
W
T
:
5
m
/
1
1
f
R
A
T
T
:
6
.
5
(
r
a
n
g
e
:
6
–
7
.
5
)
,
C
W
T
:
6
.
5
(
r
a
n
g
e
:
6
–
7
.
5
)
R
A
T
T
:
4
9
.
7
(
S
D
1
1
)
,
C
W
T
:
5
1
(
S
D
1
5
.
5
)
C
h
r
o
n
i
c
P
,
R
R
P
r
o
s
p
e
c
t
i
v
e
R
C
T
,
c
o
m
p
a
r
i
n
g
R
A
T
T
w
i
t
h
C
W
T
R
A
T
T
:
B
W
S
T
T
+
L
o
k
o
m
a
t
(
n
=
1
9
→
n
=
1
4
)
,
C
W
T
:
c
o
n
v
e
n
t
i
o
n
a
l
w
a
l
k
i
n
g
t
r
a
i
n
i
n
g
(
n
=
1
6
→
n
=
1
5
)
R
A
T
T
:
i
n
i
t
i
a
l
B
W
S
(
4
0
–
8
0
%
)
,
a
s
s
i
s
t
a
n
c
e
o
f
l
e
g
m
o
v
e
m
e
n
t
s
(
4
0
–
1
0
0
%
)
a
n
d
s
p
e
e
d
(
1
–
1
.
5
k
m
p
h
/
0
.
2
8
–
0
.
4
2
m
/
s
)
.
↓
B
W
S
a
n
d
a
s
s
i
s
t
a
n
c
e
a
n
d
↑
s
p
e
e
d
.
C
W
T
:
w
a
l
k
i
n
g
o
v
e
r
g
r
o
u
n
d
w
i
t
h
o
r
w
i
t
h
o
u
t
w
a
l
k
i
n
g
a
i
d
s
,
w
i
t
h
a
s
s
i
s
t
a
n
c
e
.
1
5
s
e
s
s
i
o
n
s
,
3
0
m
i
n
,
5
x
/
w
W
a
l
k
i
n
g
s
p
e
e
d
(
2
0
M
W
T
)
,
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
(
6
M
W
T
)
,
s
t
r
i
d
e
l
e
n
g
t
h
(
c
m
)
B
a
s
e
l
i
n
e
,
a
f
t
e
r
3
w
a
n
d
a
t
f
o
l
l
o
w
u
p
a
f
t
e
r
6
m
.
A
f
t
e
r
R
A
T
T
:
s
i
g
n
.
↑
w
a
l
k
i
n
g
s
p
e
e
d
a
n
d
e
n
d
u
r
a
n
c
e
.
A
f
t
e
r
C
W
T
:
s
i
g
n
.
↑
w
a
l
k
i
n
g
s
p
e
e
d
s
.
N
o
s
i
g
n
.
d
i
ﬀ
e
r
e
n
c
e
s
b
e
t
w
e
e
n
g
r
o
u
p
s
.
F
o
l
l
o
w
u
p
(
n
=
2
3
)
:
o
u
t
c
o
m
e
v
a
l
u
e
s
r
e
t
u
r
n
e
d
t
o
b
a
s
e
l
i
n
e
.
V
a
n
e
y
e
t
a
l
.
(
2
0
1
1
)
[
3
0
]
t
r
u
e
e
x
p
.
(
7
7
%
)
4
9
(
6
7
:
1
8
d
r
o
p
-
o
u
t
s
)
?
R
A
T
T
:
5
.
9
(
S
D
0
.
9
0
,
r
a
n
g
e
:
3
–
6
.
5
)
C
W
T
:
5
.
7
(
S
D
1
.
0
6
,
r
a
n
g
e
:
3
–
6
.
5
)
R
A
T
T
:
5
8
.
2
(
S
D
9
.
4
2
,
r
a
n
g
e
:
3
7
–
7
3
)
C
W
T
:
5
4
.
2
(
S
D
1
1
.
2
8
,
r
a
n
g
e
:
3
6
–
7
4
)
,
?
R
C
T
c
o
m
p
a
r
i
n
g
R
A
T
T
w
i
t
h
C
W
T
R
A
T
T
:
B
W
S
T
T
+
L
o
k
o
m
a
t
(
n
=
2
6
)
,
C
W
T
:
w
a
l
k
i
n
g
i
n
g
r
o
u
p
w
i
t
h
p
h
y
s
i
o
t
h
e
r
a
-
p
i
s
t
(
n
=
2
3
)
R
A
T
T
:
i
n
i
t
i
a
l
B
W
S
5
0
%
,
i
n
d
i
v
i
d
u
a
l
l
y
a
d
a
p
t
e
d
,
s
p
e
e
d
:
r
e
g
u
l
a
t
e
d
o
n
g
a
i
t
o
b
s
e
r
v
a
t
i
o
n
,
i
n
i
t
i
a
l
g
u
i
d
a
n
c
e
1
0
0
%
a
n
d
r
e
d
u
c
e
d
a
s
m
u
c
h
a
s
p
o
s
s
i
b
l
e
.
C
W
T
:
i
n
g
y
m
r
o
o
m
o
r
o
u
t
s
i
d
e
o
n
u
n
e
v
e
n
g
r
o
u
n
d
+
w
a
l
k
i
n
g
a
i
d
s
.
R
A
T
T
:
6
t
o
1
0
(
m
e
a
n
9
)
s
e
s
s
i
o
n
s
,
C
W
T
:
7
t
o
1
0
(
m
e
a
n
8
)
s
e
s
s
i
o
n
s
.
3
0
m
i
n
.
W
a
l
k
i
n
g
s
p
e
e
d
(
1
0
M
W
T
,
3
M
W
T
o
n
8
0
m
h
a
l
l
w
a
y
)
B
a
s
e
l
i
n
e
,
a
f
t
e
r
t
r
e
a
t
m
e
n
t
.
I
n
b
o
t
h
g
r
o
u
p
s
:
↑
w
a
l
k
i
n
g
s
p
e
e
d
.
N
o
s
i
g
n
.
b
e
t
w
e
e
n
-
g
r
o
u
p
d
i
ﬀ
e
r
e
n
c
e
s
.
s
i
g
n
.
↑
w
a
l
k
i
n
g
s
p
e
e
d
,
b
e
t
w
e
e
n
g
r
o
u
p
d
i
ﬀ
e
r
e
n
c
e
w
a
s
i
n
f
a
v
o
r
o
f
t
h
e
C
W
T
.Multiple Sclerosis International 7
T
a
b
l
e
3
:
C
o
n
t
i
n
u
e
d
.
R
e
f
e
r
e
n
c
e
.
P
a
r
t
i
c
i
p
a
n
t
s
I
n
t
e
r
v
e
n
t
i
o
n
(
+
C
o
m
p
a
r
i
s
o
n
)
O
u
t
c
o
m
e
R
e
s
u
l
t
s
A
u
t
h
o
r
(
y
e
a
r
)
S
t
u
d
y
(
M
Q
S
)
N
u
m
b
e
r
M
a
l
e
/
f
e
m
a
l
e
E
D
S
S
s
c
o
r
e
A
g
e
T
y
p
e
M
S
D
e
s
i
g
n
T
y
p
e
S
p
e
e
d
/
B
W
S
S
e
s
s
i
o
n
s
O
u
t
c
o
m
e
-
m
e
a
s
u
r
e
m
e
n
t
s
A
s
s
e
s
s
m
e
n
t
t
i
m
e
s
G
a
i
t
-
r
e
l
a
t
e
d
o
u
t
c
o
m
e
m
e
a
s
u
r
e
m
e
n
t
s
S
c
h
w
a
r
t
z
e
t
a
l
.
(
2
0
1
1
)
[
3
1
]
t
r
u
e
e
x
p
.
(
7
7
%
)
2
8
(
3
2
:
4
d
r
o
p
o
u
t
s
;
1
i
n
C
W
T
,
3
i
n
R
A
T
T
)
F
o
l
l
o
w
-
u
p
3
m
n
=
2
4
,
6
m
n
=
1
8
1
4
m
/
1
8
f
R
A
T
T
:
7
m
/
8
f
,
C
W
T
:
7
m
/
1
0
f
R
A
T
T
:
6
.
2
(
S
D
0
.
5
,
r
a
n
g
e
:
5
.
5
–
7
)
,
C
W
T
:
6
(
S
D
0
.
6
,
r
a
n
g
e
:
5
–
7
)
R
A
T
T
:
4
6
.
8
(
S
D
1
1
.
5
,
r
a
n
g
e
:
2
9
–
6
9
)
,
C
W
T
:
5
0
.
5
(
S
D
1
1
.
5
,
r
a
n
g
e
:
2
8
–
7
0
)
R
P
,
S
P
,
P
P
P
r
o
s
p
e
c
t
i
v
e
R
C
T
R
A
T
T
:
B
W
S
T
T
+
L
o
k
o
m
a
t
(
n
=
1
5
)
,
C
W
T
:
g
a
i
t
a
n
d
d
y
n
a
m
i
c
b
a
l
a
n
c
e
e
x
e
r
c
i
s
e
s
,
s
t
a
n
d
i
n
g
f
r
o
m
s
i
t
t
i
n
g
t
r
a
i
n
i
n
g
a
n
d
w
a
l
k
i
n
g
w
i
t
h
o
r
w
i
t
h
o
u
t
w
a
l
k
i
n
g
a
i
d
s
(
n
=
1
7
)
.
R
A
T
T
:
i
n
i
t
i
a
l
B
W
S
:
4
0
%
,
a
f
t
e
r
2
w
3
0
%
,
a
f
t
e
r
4
w
2
0
%
.
s
p
e
e
d
:
m
a
x
i
m
u
m
s
p
e
e
d
t
o
l
e
r
a
t
e
d
.
1
2
s
e
s
s
i
o
n
s
,
3
0
m
i
n
,
2
–
3
x
/
w
f
o
r
4
w
W
a
l
k
i
n
g
s
p
e
e
d
(
1
0
M
W
T
)
,
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
(
6
M
W
T
)
,
d
i
s
a
b
i
l
i
t
y
(
E
D
S
S
)
B
a
s
e
l
i
n
e
,
a
f
t
e
r
4
w
,
f
o
l
l
o
w
u
p
a
f
t
e
r
3
a
n
d
6
m
.
A
f
t
e
r
C
W
T
:
s
i
g
n
.
↑
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
a
n
d
s
p
e
e
d
a
n
d
↓
E
D
S
S
.
A
f
t
e
r
R
A
T
T
:
n
o
s
i
g
n
.
↑
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
a
n
d
s
p
e
e
d
,
s
i
g
n
.
↓
E
D
S
S
.
F
o
l
l
o
w
u
p
:
o
u
t
c
o
m
e
v
a
l
u
e
s
r
e
t
u
r
n
e
d
t
o
b
a
s
e
l
i
n
e
.
L
o
a
n
d
T
r
i
c
h
e
(
2
0
0
8
)
[
3
2
]
t
r
u
e
e
x
p
.
(
7
1
%
)
1
3
7
m
/
6
f
4
.
9
(
S
D
1
.
2
)
4
9
.
8
(
S
D
1
1
.
1
)
R
R
S
P
(
n
=
8
)
,
P
P
(
n
=
5
)
p
r
o
s
p
e
c
t
i
v
e
r
a
n
d
o
m
-
i
z
e
d
p
i
l
o
t
s
t
u
d
y
,
r
a
n
-
d
o
m
i
z
e
d
c
r
o
s
s
-
o
v
e
r
d
e
s
i
g
n
,
R
A
T
T
-
B
W
S
T
T
(
n
=
6
)
,
B
W
S
T
T
-
R
A
T
T
(
n
=
7
)
(
1
)
B
W
S
T
T
f
o
l
l
o
w
e
d
b
y
B
W
S
T
T
+
L
o
k
o
m
a
t
o
r
(
2
)
B
W
S
T
T
+
L
o
k
o
m
a
t
f
o
l
l
o
w
e
d
b
y
B
W
S
T
T
.
A
f
t
e
r
1
s
t
p
h
a
s
e
(
T
2
)
,
6
-
w
e
e
k
w
a
s
h
o
u
t
p
e
r
i
o
d
(
T
3
)
,
c
r
o
s
s
e
d
-
o
v
e
r
t
o
t
h
e
a
l
t
e
r
n
a
t
e
t
r
e
a
t
m
e
n
t
.
I
n
i
t
i
a
l
B
W
S
:
3
0
%
t
o
4
0
%
,
i
n
i
t
i
a
l
s
p
e
e
d
:
1
.
5
k
m
p
h
(
0
.
4
2
m
/
s
)
.
↑
s
p
e
e
d
t
o
2
.
2
t
o
2
.
5
k
m
p
h
(
0
.
6
1
t
o
0
.
6
9
m
/
s
)
b
e
f
o
r
e
↓
B
W
S
1
2
s
e
s
s
i
o
n
s
(
6
/
p
h
a
s
e
)
,
4
0
m
i
n
,
2
x
/
w
W
a
l
k
i
n
g
s
p
e
e
d
(
T
2
5
F
W
)
,
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
(
6
M
W
T
o
n
t
r
e
a
d
m
i
l
l
)
,
d
i
s
a
b
i
l
i
t
y
(
E
D
S
S
)
T
1
(
b
a
s
e
l
i
n
e
)
,
T
2
(
a
f
t
e
r
ﬁ
r
s
t
p
h
a
s
e
,
3
w
)
,
T
4
(
e
n
d
s
t
u
d
y
,
1
2
w
)
↑
w
a
l
k
i
n
g
s
p
e
e
d
,
↑
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
(
n
=
1
2
)
,
↓
d
o
u
b
l
e
l
i
m
b
s
u
p
p
o
r
t
t
i
m
e
(
n
=
1
2
)
.
↓
E
D
S
S
.
N
o
s
i
g
n
.
d
i
ﬀ
e
r
e
n
c
e
s
d
u
e
t
o
t
r
e
a
t
m
e
n
t
o
r
d
e
r
.8 Multiple Sclerosis International
T
a
b
l
e
3
:
C
o
n
t
i
n
u
e
d
.
R
e
f
e
r
e
n
c
e
.
P
a
r
t
i
c
i
p
a
n
t
s
I
n
t
e
r
v
e
n
t
i
o
n
(
+
C
o
m
p
a
r
i
s
o
n
)
O
u
t
c
o
m
e
R
e
s
u
l
t
s
A
u
t
h
o
r
(
y
e
a
r
)
S
t
u
d
y
(
M
Q
S
)
N
u
m
b
e
r
M
a
l
e
/
f
e
m
a
l
e
E
D
S
S
s
c
o
r
e
A
g
e
T
y
p
e
M
S
D
e
s
i
g
n
T
y
p
e
S
p
e
e
d
/
B
W
S
S
e
s
s
i
o
n
s
O
u
t
c
o
m
e
-
m
e
a
s
u
r
e
m
e
n
t
s
A
s
s
e
s
s
m
e
n
t
t
i
m
e
s
G
a
i
t
-
r
e
l
a
t
e
d
o
u
t
c
o
m
e
m
e
a
s
u
r
e
m
e
n
t
s
v
a
n
d
e
n
B
e
r
g
e
t
a
l
.
(
2
0
0
6
)
[
3
3
]
t
r
u
e
e
x
p
.
(
6
2
.
5
%
)
1
6
(
1
9
:
3
d
r
o
p
o
u
t
s
)
3
m
/
1
3
f
?
(
a
b
l
e
t
o
w
a
l
k
1
0
m
(
u
s
i
n
g
a
i
d
s
i
f
r
e
q
u
i
r
e
d
)
i
n
l
e
s
s
t
h
a
n
6
0
s
+
c
o
u
l
d
w
a
l
k
s
a
f
e
l
y
o
n
t
r
e
a
d
m
i
l
l
w
i
t
h
o
u
t
t
h
e
r
a
p
i
s
t
o
r
B
W
s
u
p
p
o
r
t
.
I
T
:
3
0
–
6
5
,
D
T
:
3
0
–
6
5
?
R
C
T
,
p
i
l
o
t
s
t
u
d
y
(
r
a
n
d
o
m
.
)
c
r
o
s
s
o
v
e
r
d
e
s
i
g
n
.
T
T
,
I
T
:
t
r
a
i
n
i
n
g
-
n
o
t
r
a
i
n
i
n
g
(
n
=
8
)
;
D
T
:
n
o
t
r
a
i
n
i
n
g
-
t
r
a
i
n
i
n
g
(
n
=
8
)
.
W
a
l
k
i
n
g
d
u
r
a
t
i
o
n
↑
a
s
t
o
l
e
r
a
t
e
d
,
u
p
t
o
m
a
x
3
0
m
i
n
w
i
t
h
a
m
a
x
o
f
3
r
e
s
t
p
e
r
i
o
d
s
.
O
n
c
e
m
a
x
w
a
l
k
i
n
g
d
u
r
a
t
i
o
n
w
a
s
a
t
t
a
i
n
e
d
,
i
n
t
e
n
s
i
t
y
↑
b
y
↑
s
p
e
e
d
.
E
n
c
o
u
r
a
g
e
d
:
5
5
–
8
5
%
o
f
a
g
e
-
p
r
e
d
i
c
t
e
d
m
a
x
H
R
.
1
2
s
e
s
s
i
o
n
s
,
3
0
m
i
n
,
3
x
/
w
W
a
l
k
i
n
g
s
p
e
e
d
(
1
0
M
W
T
)
,
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
(
2
M
W
T
)
B
a
s
e
l
i
n
e
,
w
e
e
k
7
(
T
1
)
a
n
d
1
2
(
T
2
)
A
t
T
1
:
↑
w
a
l
k
i
n
g
e
n
d
u
r
a
n
c
e
;
t
r
a
i
n
e
d
g
r
o
u
p
s
i
g
n
.
↑
w
a
l
k
i
n
g
s
p
e
e
d
c
o
m
p
a
r
e
d
t
o
u
n
t
r
a
i
n
e
d
g
r
o
u
p
.
A
t
T
2
:
w
a
l
k
i
n
g
p
e
r
f
o
r
m
a
n
c
e
r
e
t
u
r
n
e
d
t
o
w
a
r
d
b
a
s
e
l
i
n
e
s
c
o
r
e
s
.
N
e
w
m
a
n
e
t
a
l
.
(
2
0
0
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toward greater normalization of the double support time for
those randomized to the treadmill group compared to the
robot group (−5.9% versus −1.9%, P = 0.06) (moderate
eﬀect size) was found in the study of Lo and Triche (2008).
Furthermore these authors found no signiﬁcant changes in
step length ratio after treatment nor signiﬁcant diﬀerences
between the two groups for step length ratio (0.004 versus
0.02) [32]. Newman et al. (2007) reported no signiﬁcant
diﬀerence in cadence after training. A signiﬁcant increase
in swing phase time of the weak leg (baseline: 33% ± 9.3
(range: 1.7 to 42.7), posttraining: 36% ± 4.5 (range: 26.7
to 41.7); P = 0.03, small eﬀect size), a signiﬁcant decrease
in stand phase time of the weak leg (baseline: 67% ± 9.3
(range: 57.3 to 98.3), posttraining: 63.8% ± 4.5 (range: 58.3
to 73.4) P = 0.03, small eﬀect size) and a signiﬁcant increase
in stride length of the strong leg (Baseline: 98.7%±21 range:
65.5 to 135.0, posttraining: 104.0%±21 range: 75.4 to 146.0;
P = 0.04) were described [34]. Beer et al. (2008) reported
a nonsigniﬁcant small eﬀect (eﬀect size 0.2 to 0.4) for stride
length [29].
3.2. Research Question 2: Is Any of the Therapies (TT, BWSTT,
Or RATT) Superior to the Other Therapies in Terms of Gait-
Related Outcome Measurements? Four studies (four RCTs)
compared diﬀerent types of gait training. Three studies
compared RATT with over-ground CWT and one study
RATT with BWSTT. Comparing CWT with the RATT, Beer
et al. (2008) found in their RCT a higher beneﬁt in walking
velocity and knee extensor strength by RATT compared to
CWT. They concluded that RATT treatment might actually
be an eﬀective treatment option for the subgroup of persons
with MS with severe walking disabilities [29]. The study of
Schwartzetal.(2011)reportedthattheyfoundnosigniﬁcant
diﬀerences in mean and mean change from baseline of
gait parameters and EDSS score between the RATT and
CWT in both groups [31]. The RCT of Vaney et al. (2011)
found a weak evidence that the walking group improved
more in the 3MWT and the 10MWT compared with the
RATT group. But, after correction for multiple testing there
were no signiﬁcant between-group diﬀerences [30]. The
RCT of Lo and Triche (2008) based on a cross-over design
for BWSTT and RATT reported signiﬁcant within-subjects
improvements but no signiﬁcant diﬀerences between the
treatment groups [32].
3.3. Research Question 3: What Are the Long Term-Eﬀects?
Van den Berg et al. (2006) described that after twelve weeks,
including a four-week rest period, the walking performance
returned toward baseline scores [33]. One RCT measured
followup data after six months and reported that the
outcome values returned to baseline in both groups (RATT
and CWT) [29]. The RCT of Schwartz et al. (2011) did
a followup at three and six months. At three months, the
6MWT and EDSS improved signiﬁcantly only in the CWT
group and the 10MWT had not changed in either group.
At six months the 6MWT, 10MWT, and EDSS scores are
returned to baseline scores in both groups. After calculating
the eﬀect score a small eﬀect was found for EDSS after six
months [31].
4. Discussion
With this paper it can be established that only a few studies
have been published that investigated gait-related outcome
measurements, such as walking speed and endurance, step
lengthand EDSSscore,afterTTwithor withoutBWS and/or
RA,inpersonswithMS.TheresultssuggestthatTT,BWSTT,
and RATT improve the walking speed and maximal walking
distance in persons with MS, but it is not clear what type of
TT intervention is the most eﬀective.
This systematic review included pre-, quasi-, and true-
experimental study designs. The methodological quality of
the included studies was good, with ﬁve RCTs with a quality
score between 62.5% and 79%, although three of the eight
included studies are preexperimental studies and therefore
of lower methodological quality. The number of subjects is
rather limited. This low number of participants is probably
due to the practical feasibility of the intervention and the
diﬃculty in selecting and motivating the patients. Diﬀerent
types of MS (RR, PP, SP, PR) and subjects with diﬀerent
gradations of gait problems were selected in the included
studies. The information on the EDSS score, type of MS,
and/or severity of gait problems was limited in some studies
or even not reported. Also the severity of the symptoms
at baseline was diﬀerent in the subjects of the diﬀerent
studies. The selection of the patients for intervention studies
is diﬃcult in the MS population because of the variability in
symptoms, the diﬀerent types of MS, and the diﬀerent and
unpredictable course of the disease [1].
The results, in terms of gait-related outcome measure-
ments, were promising with improvements in walking speed
and endurance. Hence, when comparing RATT with BWSTT
no signiﬁcant diﬀerences between these two methods were
reported. In the study of Lo and Triche (2008) some
higher eﬀect sizes were measured after BWSTT compared to
RATT. Vaney et al. (2011) reported that the between-group
diﬀerence was in favor of the CWT and not of the RATT.
However, it is not clear what type of TT intervention is most
eﬀective with respect to gait-related outcome measurements.
Furthermore, the long-term beneﬁts of TT are not suﬃ-
ciently studied at the moment. Only two studies included an
acceptable follow-up period of six months and reported that
the outcome values returned to baseline.
The positive outcome on gait speed and endurance is
important for the clinical practice. Also clinically interesting
is the ﬁnding of Giesser et al. (2007), who included only
severely aﬀected persons with MS (EDSS 7–7.5). After
about twenty BWSTT sessions, respectively, one and two
persons who could not complete the tests before the training
completed the 10MWT and the 6MWT after training [36].
This means a large impact on these patients’ autonomy. Also
interesting is the gain of 0.5 or one point in EDSS score
measured in a few patients [35, 36].
In other neurological populations, such as Stroke,
Parkinson’s disease, and SCI, more studies were conducted
on this topic and a few systematic reviews summarize the
results [19, 21–23, 26, 27, 40]. These results are similar to
the results of this paper. Some positive eﬀects are reported
on gait parameters, but it is unclear which therapy modalityMultiple Sclerosis International 13
is most eﬀective. In acute and subacute patients after stroke
(more than in patients treated more than three months after
stroke), the use of RATT interventions in combination with
physiotherapyincreasedthechanceofregainingindependent
walking ability for patients, but it was not associated with
improvements in walking velocity nor walking capacity [40].
In Parkinson’s disease TT improved gait speed, stride length,
walking distance, but cadence did not improve at the end of
study [26]. Also in SCI populations there are some positive
results on gait-related outcome measurements, but there
is insuﬃcient evidence to conclude that any approach to
locomotor training is more eﬀective than any other for
improving the walking function of people with SCI [22, 27].
Comparable to the results in persons with MS in any of
these other neurological disorders, the long-term eﬀects of
the diﬀerent therapies are not clear at the moment.
We included studies that used TT in its diﬀerent forms
(TT, BWSTT, and RATT). We are aware that diﬀerent types
of walking training lead to diﬀerences in biomechanics
and physiology [41–44]. Riley et al. (2007) have shown
that treadmill gait is qualitatively and quantitatively similar
to over-ground gait. Only small diﬀerences in kinematic
and kinetic parameters can be detected with magnitudes
within the range of repeatability of measured kinematic
parameters [44]. Hence, in healthy elderly subjects there was
a signiﬁcantly increased cadence and decreased stride length
and stride time, along with reduced joint angles, moments,
and powers measured during treadmill walking compared
to over-ground walking [43]. More diﬀerences in kinematics
occurredwhencomparingTTwithBWSandRA.Diﬀerences
among BWSTT and full weight bearing TT are a raised
center of gravity, leading to limited downward excursion, a
decreased percentage of stance, total double-limb support
time, hip and knee angular displacement, and an increased
single-limb support time. Other adaptations to BWS were
a reduced mean burst amplitude in muscles required for
weight acceptance (i.e., erector spinae and gluteus medius
muscles) and push-oﬀ (i.e., medial gastrocnemius muscle)
and an increase in mean burst amplitude in the investigated
muscle that is active during swing (i.e., tibialis anterior
muscle)[45].HigherlevelsofBWSincreasedlowerextremity
kinematic variability, with more variability at the hip joint
for older subjects [41]. Although Hidler et al. (2008)
described that the overall kinematics in the Lokomat are
similar to those on a treadmill, there was signiﬁcantly more
hip and ankle extension and greater hip and ankle range of
motion during walking in the Lokomat (P<0.05) measured
[42].
The initial percentage BWS used in the included studies
was very high in some cases, if reported the percentage
of unweighting was from 30% to more than 80% of the
body weight. Because the gait patterns (temporospatial and
kinematic changes) are signiﬁcantly changed by 50% and
70% BWS [46, 47] and also changes in EMG activity of the
musclesoccurwhenwalkingatthesehighpercentageofBWS
[48] we can doubt the eﬀect on functional gait of training in
such high percentages of BWS.
Furthermore, the eﬀort the patients make, not to men-
tion the eﬀort of the therapists and the number of therapist
needed to assist the patients, varies in the diﬀerent types
of TT. The preparation of the patients for RATT is a time
intensive process, but once they are installed in the robot
only one therapist is needed to assist the patient. TT or
BWSTT in subjects with severe impairments implies a highly
personalized and labor-intensive task for the therapist such
as in the study of Giesser et al. (2007) [36]. The number of
therapistsneededtoaccomplishthetreatmentduringTTwas
signiﬁcantly higher than during RATT intervention with the
LokoHelp in the study of Freivogel et al. (2009) [49]. This
meant a 25% increase in staﬀ requirements [49]. Because of
the limited number of studies in persons with MS on this
topic we have chosen to include the diﬀerent types of TT but
selected on speciﬁc gait-related outcome measurements.
Other issues are the physiological and psychological
eﬀects of training. Several studies reported the positive
eﬀects of TT on functional mobility, cardiovascular ﬁtness,
quality of life, and very signiﬁcant health-related beneﬁts
that may decrease the risk of secondary health complications
associated with physical inactivity [50–53]. Also wheel chair-
dependent individuals enjoy and value the normalizing
experience of seeing themselves upright and participating in
the walking motion [50].
ItisnecessarythatlargeRCTscomparethediﬀerenttypes
of TT with no training in persons with MS with subdivisions
dependingonthetypeofMSandthedegreeofindependence
togetaclearideaabouttheeﬀectivenessofthediﬀerenttypes
of TT.
5. Conclusions
We can conclude that actually there is a limited amount
o fl i t e r a t u r er e l a t e dt oT T ,B W S T T ,a n dR A T Ti np e r s o n s
with MS, suggesting that TT, BWSTT, and RATT improve
the walking speed and maximal walking distance in persons
with MS. Although there are some promising results for
RATT, it is not clear what type of TT intervention is
the most eﬀective. Therefore, RCTs with larger but more
homogeneous populations are needed.
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